Previous studies have compared the proteomic profiles of depressed patients and healthy controls, finding that in atypical depression, but not melancholic, both IGFBP-1 and IGFBP-2 were significantly decreased [64]. Here, IGFBP1 is linked to depressive symptom measurement.